Rapid analysis of glycolytic and oxidative substrate flux of cancer cells in a microplate

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Pike Winer, Lisa S ^a   Wu, Min ^a,b  

^a Seahorse Bioscience Inc   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUTAMINE; GLUCOSE;

ACIDIFICATION; AMINO ACID METABOLISM; ARTICLE; BIOENERGY; CELL PROLIFERATION; CELL VIABILITY; CITRIC ACID CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPIGENETICS; FATTY ACID OXIDATION; GLIOBLASTOMA CELL LINE; GLUCOSE OXIDATION; GLYCOLYSIS; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; OXIDATION KINETICS; OXIDATIVE PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL RESPIRATION; DEVICES; GLIOBLASTOMA; METABOLISM; MITOCHONDRION; MOLECULAR BIOLOGY; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; PHYSIOLOGY; PROCEDURES;

CELL PROLIFERATION; CELL RESPIRATION; FATTY ACIDS; GLIOBLASTOMA; GLUCOSE; GLUTAMINE; GLYCOLYSIS; HUMANS; MITOCHONDRIA; MOLECULAR BIOLOGY; OXIDATION-REDUCTION; OXYGEN CONSUMPTION;

EID: 84910020013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109916     Document Type: Article

References (45)

1. Warburg O, Posener K, Negelein E (1924) Über den Stoffwechsel der Carcinomzelle. Biochem Zeitschr 152: 35.
2. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314.
3. Baggetto LG (1992) Deviant energetic metabolism of glycolytic cancer cells. Biochimie 74: 959-974.
4. Medina MA (2001) Glutamine and cancer. The Journal of nutrition 131: 2539S-2542S; discussion 2550S-2531S.
5. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, et al. (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences of the United States of America 104: 19345-19350.
6. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, et al. (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America 105: 18782-18787.
7. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, et al. (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458: 762-765.
8. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nature reviews Cancer 4: 891-899.
9. Pedersen PL (2007) Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. Journal of bioenergetics and biomembranes 39: 211-222.
10. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
11. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nature reviews Cancer 11: 325-337.
12. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell metabolism 7: 11-20.
13. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: metabolism and tumor cell growth. Current opinion in genetics & development 18: 54-61.
14. Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer cell 21: 297-308.
15. Yuneva MO, Fan TW, Allen TD, Higashi RM, Ferraris DV, et al. (2012) The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell metabolism 15: 157-170.
16. Casey JR, Grinstein S, Orlowski J (2010) Sensors and regulators of intracellular pH. Nature reviews Molecular cell biology 11: 50-61.
17. Hochachka PW, Mommsen TP (1983) Protons and anaerobiosis. Science 219: 1391-1397.
18. Lane AN, Fan TW, Higashi RM (2009) Metabolic acidosis and the importance of balanced equations. Metabolomics 5: 3.
19. Kemp G (2005) Lactate accumulation, proton buffering, and pH change in ischemically exercising muscle. American journal of physiology Regulatory, integrative and comparative physiology 289: R895-901; author reply R904-910.
20. Ipata PB, Francesco (2012) Glycogen as a fuel: metabolic interaction between glycogen and ATP catabolism in oxygen-independent muscle contraction. Metabolomics 8.
21. Brooks GA (2010) What does glycolysis make and why is it important? Journal of applied physiology 108: 1450-1451.
22. Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292: C125-136.
23. Turrens JF (2003) Mitochondrial formation of reactive oxygen species. The Journal of physiology 552: 335-344.
24. Brookes PS (2005) Mitochondrial H(+) leak and ROS generation: an odd couple. Free radical biology & medicine 38: 12-23.
25. Xie H, Valera VA, Merino MJ, Amato AM, Signoretti S, et al. (2009) LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer. Mol Cancer Ther 8: 626-635.
26. Chan DA, Sutphin PD, Nguyen P, Turcotte S, Lai EW, et al. (2011) Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality. Sci Transl Med 3: 94ra70.
27. Zhang J, Nuebel E, Wisidagama DR, Setoguchi K, Hong JS, et al. (2012) Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cells. Nat Protoc 7: 1068-1085.
28. Crabtree HG (1929) Observations on the carbohydrate metabolism of tumours. The Biochemical journal 23: 536-545.
29. Fan TW, Lane AN, Higashi RM, Farag MA, Gao H, et al. (2009) Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM). Molecular cancer 8: 41.
30. Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M (2010) Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta.
31. Samudio I, Kurinna S, Ruvolo P, Korchin B, Kantarjian H, et al. (2008) Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells. Molecular cancer therapeutics 7: 1130-1139.
32. Carracedo A, Cantley LC, Pandolfi PP (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nature reviews Cancer 13: 227-232.
33. Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, et al. (2012) Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer cell 22: 547-560.
34. Zaugg K, Yao Y, Reilly PT, Kannan K, Kiarash R, et al. (2011) Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes & development 25: 1041-1051.
35. Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, et al. (1986) Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proceedings of the National Academy of Sciences of the United States of America 83: 470-473.
36. Choi SW, Gerencser AA, Nicholls DG (2009) Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure. J Neurochem 109: 1179-1191.
37. Hill BG, Dranka BP, Zou L, Chatham JC, Darley-Usmar VM (2009) Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. Biochem J 424: 99-107.
38. Ibrahim-Hashim A, Wojtkowiak JW, Ribeiro MdLC, Estrella V, Bailey KM, et al. (2011) Free Base Lysine Increases Survival and Reduces Metastasis in Prostate Cancer Model. J Cancer Sci Ther S1.
39. Rivenzon-Segal D, Boldin-Adamsky S, Seger D, Seger R, Degani H (2003) Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. International journal of cancer Journal international du cancer 107: 177-182.
40. Artemov D, Bhujwalla ZM, Pilatus U, Glickson JD (1998) Two-compartment model for determination of glycolytic rates of solid tumors by in vivo 13C NMR spectroscopy. NMR in biomedicine 11: 395-404.
41. Mathupala SP, Heese C, Pedersen PL (1997) Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. The Journal of biological chemistry 272: 22776-22780.
42. Ye J, Mancuso A, Tong X, Ward PS, Fan J, et al. (2012) Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 109: 6904-6909.
43. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, et al. (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25: 460-470.
44. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, et al. (2009) Autophagy regulates lipid metabolism. Nature 458: 1131-1135.
45. Swift AL, Chen D, Pike LS, Fisher K, Winer M, et al. (2011) KSR1, a molecular scaffold of the Ras-Raf-MEK-ERK kinase cascade that is necessary for H-RasV12-induced oncogenic transformation, is also required for uptake/consumption of glucose and glutamine in mouse embryonic fibroblasts. F1000 Posters 2: 52 (poster)